Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Insulin Pens, Syringes, Pumps And Injectors Market From 2025 To 2029?
The market for insulin pens, syringes, pumps and injectors has experienced a swift expansion in recent times. The market size is set to increase from $21.6 billion in 2024 to $24.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.3%. This growth in the prior period can be associated with factors such as urbanization, infrastructure enhancement, power provision in rural locations, industrial development, and the incorporation of renewable energy.
What Is the Projected Market Size of the Insulin Pens, Syringes, Pumps And Injectors Market?
The market size of insulin pens, syringes, pumps, and injectors is anticipated to witness significant expansion in the ensuing years reaching a figure of $37.86 billion by 2029, with a Compound Annual Growth Rate (CAGR) amounting to 11.8%. The surge projected for the forecast duration can be traced back to factors like energy conversion, the electrification of travel means, integration of smart grids and IoT, the proliferation of 5G, and the replacement of aged infrastructures. Key trends that are expected to make an impact for the same term include the adoption of high-voltage direct current (HVDC) cables, utilization of fire-resistant insulation materials, integration of fiber optics, use of eco-friendly materials, and emphasis on customization and specialization.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3806&type=smp
Who are the Major Competitors in the Insulin Pens, Syringes, Pumps And Injectors Market Outlook?
Major companies operating in the insulin pens, syringes, pumps and injectors market include Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, Insulet Corporation, Sanofi Aventis, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Animas Corporation, Ypsomed Holding AG, Dickinson and Company, Valeritas Inc., MannKind Corporation, Tandem Diabetes Care Inc., Biocon Ltd., B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Nipro Corporation, Smiths Medical Inc., Owen Mumford, UltiMed Inc., Ypsomed Holding, Ascensia Diabetes Care, Trividia Health, ARKRAY Inc., AgaMatrix Inc., Medline Industries LP, Gerresheimer AG, West Pharmaceutical Services Inc., SHL Medical AG, Zhejiang POCTech Medical Co.Ltd., Jiangsu Wanhai Medical Instruments Co. Ltd.
What Is Fueling Growth in the Insulin Pens, Syringes, Pumps And Injectors Market?
The insulin pens, syringes, pumps, and injectors market is expanding due to a surge in the global occurrence of diabetes. Diabetes is a chronic disease where the body doesn’t make enough insulin or doesn’t efficiently use the insulin it makes, leading to high blood sugar levels. The rise in diabetes on a global scale is driven by a multitude of factors such as obesity, poor diet, lack of physical activity, and a growing elderly population. These factors contribute to an increased need for insulin delivery devices as more people need insulin pens, syringes, pumps, and injectors to manage their condition effectively and conveniently. For example, in 2021, the International Diabetes Federation, a Belgium-based organization representing over 240 national diabetes associations, reported that around 537 million adults worldwide were dealing with diabetes, and this figure is predicted to jump to 783 million by 2045. Consequently, the growth of the insulin pens, syringes, pumps, and injectors market is propelled by the surging prevalence of diabetes around the world.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=3806&type=smp
Which Insulin Pens, Syringes, Pumps And Injectors Market Segments Are Growing the Fastest?
The insulin pens, syringes, pumps and injectors market covered in this report is segmented –
1) By Type: Pens, Injectors And Pumps, Syringes
2) By Pens: Reusable, Disposable
3) By Pumps: Tubed Pumps, Tubeless Pumps
4) By End Users: Hospitals, Homecare, Other End Users
Subsegments:
1) By Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) By Injectors And Pumps: Insulin Injectors, Insulin Pumps, Traditional Insulin Pumps, Patch Insulin Pumps
3) By Syringes: Disposable Syringes, Reusable Syringes
Which Industry Trends Are Shaping the Future of the Insulin Pens, Syringes, Pumps And Injectors Market?
Numerous businesses in the insulin pens, syringes, pumps, and injectors market are paying attention to enhancing insulin delivery systems with the newest technologies to securely and effectively administer insulin. These insulin delivery tools, including devices like pens, syringes, pumps and injectors, are designed to deliver insulin to diabetes patients, ensuring accurate blood sugar control. For example, Insulet Corporation, an American medical equipment production firm, introduced the Omnipod 5 in June 2024. This equipment is a tubeless automatic insulin delivery mechanism for individuals aged two and above with type 1 diabetes. It has the unique capability to synchronize with both the Dexcom G6 and Abbott FreeStyle Libre 2 Plus continuous glucose monitors, marking it as the first system of its kind. This compatibility with leading CGM brands enhances the diabetes management process.
Access The Full Report Here:
Which Countries Are Leading the Insulin Pens, Syringes, Pumps And Injectors Market?
North America was the largest region in the global insulin pens, syringes, pumps, and injectors devices and equipment market in 2023. Asia-Pacific was the second-largest region in insulin pens, syringes, pumps, and injectors devices and equipment market. The regions covered in the insulin pens, syringes, pumps and injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3806
This Report Delivers Insight On:
1. How big is the insulin pens, syringes, pumps and injectors market, and how is it changing globally?
2. Who are the major companies in the insulin pens, syringes, pumps and injectors market, and how are they performing?
3. What are the key opportunities and risks in the insulin pens, syringes, pumps and injectors market right now?
4. Which products or customer segments are growing the most in the insulin pens, syringes, pumps and injectors market?
5. What factors are helping or slowing down the growth of the insulin pens, syringes, pumps and injectors market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
